A new drug that could help more than 128 million Americans read without needing glasses has been submitted to the Food and Drug Administration for approval.
The investigational eye drop – called AGN-190584 – is expected to be approved by the end of this year, according to a statement released last week by Allergan Eye Care, an AbbVie company.
